EE03380B1 - Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod - Google Patents
Farmatseutiline aerosoolpreparaat ja selle valmistamismeetodInfo
- Publication number
- EE03380B1 EE03380B1 EE9700061A EE9700061A EE03380B1 EE 03380 B1 EE03380 B1 EE 03380B1 EE 9700061 A EE9700061 A EE 9700061A EE 9700061 A EE9700061 A EE 9700061A EE 03380 B1 EE03380 B1 EE 03380B1
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- aerosol formulation
- pharmaceutical aerosol
- pharmaceutical
- formulation
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000008249 pharmaceutical aerosol Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9419536A GB9419536D0 (en) | 1994-09-28 | 1994-09-28 | Medicaments |
PCT/IB1995/000866 WO1996009816A1 (en) | 1994-09-28 | 1995-09-27 | Medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
EE9700061A EE9700061A (et) | 1997-08-15 |
EE03380B1 true EE03380B1 (et) | 2001-04-16 |
Family
ID=10762008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EE9700061A EE03380B1 (et) | 1994-09-28 | 1995-09-27 | Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod |
Country Status (32)
Country | Link |
---|---|
US (1) | US5849265A (ro) |
EP (1) | EP0783302B1 (ro) |
JP (1) | JPH10506887A (ro) |
KR (1) | KR100375469B1 (ro) |
CN (1) | CN1084614C (ro) |
AP (1) | AP742A (ro) |
AT (1) | ATE187063T1 (ro) |
AU (1) | AU707922B2 (ro) |
BG (1) | BG62839B1 (ro) |
BR (1) | BR9509108A (ro) |
CZ (1) | CZ286356B6 (ro) |
DE (1) | DE69513671T2 (ro) |
DK (1) | DK0783302T3 (ro) |
EE (1) | EE03380B1 (ro) |
ES (1) | ES2140706T3 (ro) |
FI (1) | FI971279A (ro) |
GB (1) | GB9419536D0 (ro) |
GE (1) | GEP20002140B (ro) |
GR (1) | GR3032245T3 (ro) |
HU (1) | HU221856B1 (ro) |
IS (1) | IS1991B (ro) |
MD (1) | MD1900C2 (ro) |
MX (1) | MX9702149A (ro) |
NO (1) | NO313658B1 (ro) |
NZ (1) | NZ292995A (ro) |
OA (1) | OA10603A (ro) |
PL (1) | PL181453B1 (ro) |
RO (1) | RO118564B1 (ro) |
RU (1) | RU2157188C2 (ro) |
SK (1) | SK281519B6 (ro) |
UA (1) | UA47412C2 (ro) |
WO (1) | WO1996009816A1 (ro) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9410222D0 (en) * | 1994-05-21 | 1994-07-06 | Glaxo Wellcome Australia Ltd | Medicaments |
US6039932A (en) * | 1996-09-27 | 2000-03-21 | 3M Innovative Properties Company | Medicinal inhalation aerosol formulations containing budesonide |
US6598603B1 (en) * | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
US6984404B1 (en) | 1998-11-18 | 2006-01-10 | University Of Florida Research Foundation, Inc. | Methods for preparing coated drug particles and pharmaceutical formulations thereof |
JP2002541183A (ja) * | 1999-04-14 | 2002-12-03 | グラクソ グループ リミテッド | 医薬用エアゾール製剤 |
US6406745B1 (en) * | 1999-06-07 | 2002-06-18 | Nanosphere, Inc. | Methods for coating particles and particles produced thereby |
GB0009606D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Therapeutic combinations |
US6451287B1 (en) | 2000-05-26 | 2002-09-17 | Smithkline Beecham Corporation | Fluorinated copolymer surfactants and use thereof in aerosol compositions |
GB0016876D0 (en) * | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Novel formulation |
US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
DZ3468A1 (fr) * | 2000-08-05 | 2002-02-14 | Glaxo Group Ltd | 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyle) oxy!-11.beta.-hydroxy-16.alpha.-methyle-3-oxo-androst-1,4,-diene-17-acide carbothioique s-fluoromethyle ester utilise comme agent anti inflammatoire |
GB0019172D0 (en) * | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
US6858593B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6750210B2 (en) * | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US6777400B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
JP2004509159A (ja) | 2000-09-22 | 2004-03-25 | グラクソ グループ リミテッド | 新規なアルカン酸誘導体 |
GB0106046D0 (en) | 2001-03-12 | 2001-05-02 | Glaxo Group Ltd | Canister |
UA77656C2 (en) * | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
CN1302007C (zh) * | 2001-04-30 | 2007-02-28 | 葛兰素集团有限公司 | 具有抗炎性的在17.α位上具有环酯基的雄甾烷的17.β.-硫代羧酸酯衍生物 |
ATE399174T1 (de) * | 2001-06-12 | 2008-07-15 | Glaxo Group Ltd | Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen |
GB0118364D0 (en) * | 2001-07-27 | 2001-09-19 | Glaxo Group Ltd | Compounds |
MXPA04001049A (es) * | 2001-08-03 | 2004-05-20 | Glaxo Group Ltd | Compuestos surfactantes y usos de los mismos. |
GB0125127D0 (en) | 2001-10-19 | 2001-12-12 | Glaxo Group Ltd | Compounds |
JP2003221335A (ja) | 2001-10-26 | 2003-08-05 | Dey Lp | 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法 |
US6702997B2 (en) | 2001-10-26 | 2004-03-09 | Dey, L.P. | Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
US20030203930A1 (en) * | 2001-10-26 | 2003-10-30 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US20030191151A1 (en) * | 2001-10-26 | 2003-10-09 | Imtiaz Chaudry | Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
US20030140920A1 (en) * | 2001-10-26 | 2003-07-31 | Dey L.P. | Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma |
US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
US7217833B2 (en) * | 2002-02-13 | 2007-05-15 | Glaxco Group Limited | Carboxylic acid compounds for use as surfactants |
GB0205327D0 (en) * | 2002-03-06 | 2002-04-17 | Glaxo Group Ltd | compounds |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
TWI359675B (en) * | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
CA2534985A1 (en) | 2003-08-11 | 2005-02-24 | Glaxo Group Limited | Pharmaceutical metered dose inhaler and methods relating thereto |
WO2005023330A2 (en) | 2003-08-29 | 2005-03-17 | Glaxo Group Limited | Pharmaceutical metered dose inhaler and methods relating thereto |
US7030255B2 (en) * | 2004-03-09 | 2006-04-18 | Lyondell Chemical Technology, L.P. | Oxidation process with in-situ H202 generation and polymer-encapsulated catalysts therefor |
EP1811981B1 (en) * | 2004-10-12 | 2008-08-13 | Merck Generics (UK) Limited | Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister |
EP1949891A1 (en) | 2004-10-12 | 2008-07-30 | Generics (UK) Limited | Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister |
GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
EP2120875B1 (en) | 2007-02-11 | 2018-07-11 | Map Pharmaceuticals Inc. | Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
GB0712454D0 (en) * | 2007-06-27 | 2007-08-08 | Generics Uk Ltd | Pharmaceutical compositions |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4352789A (en) * | 1980-03-17 | 1982-10-05 | Minnesota Mining And Manufacturing Company | Aerosol compositions containing finely divided solid materials |
GB8501015D0 (en) * | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
GB8828477D0 (en) * | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
JP2849471B2 (ja) * | 1989-06-22 | 1999-01-20 | アライアンス ファーマシューティカル コーポレイション | 界面活性剤の性質を有するフッ素およびリン含有両親媒性分子 |
GB8921222D0 (en) * | 1989-09-20 | 1989-11-08 | Riker Laboratories Inc | Medicinal aerosol formulations |
IL97065A (en) * | 1990-02-02 | 1994-01-25 | Fisons Plc | Repellent preparations for aerosol |
DE4003272A1 (de) * | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen |
DE69133314D1 (de) * | 1990-03-23 | 2003-10-23 | Minnesota Mining & Mfg | Aerosolzubereitungen zur dosierten Abgabe |
WO1992000062A1 (en) * | 1990-06-27 | 1992-01-09 | Minnesota Mining And Manufacturing Company | The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
US5126123A (en) * | 1990-06-28 | 1992-06-30 | Glaxo, Inc. | Aerosol drug formulations |
-
1994
- 1994-09-28 GB GB9419536A patent/GB9419536D0/en active Pending
-
1995
- 1995-09-27 WO PCT/IB1995/000866 patent/WO1996009816A1/en active IP Right Grant
- 1995-09-27 CN CN95196444A patent/CN1084614C/zh not_active Expired - Fee Related
- 1995-09-27 SK SK393-97A patent/SK281519B6/sk unknown
- 1995-09-27 NZ NZ292995A patent/NZ292995A/xx unknown
- 1995-09-27 DE DE69513671T patent/DE69513671T2/de not_active Expired - Fee Related
- 1995-09-27 PL PL95319342A patent/PL181453B1/pl not_active IP Right Cessation
- 1995-09-27 RO RO97-00561A patent/RO118564B1/ro unknown
- 1995-09-27 HU HU9702260A patent/HU221856B1/hu not_active IP Right Cessation
- 1995-09-27 DK DK95932166T patent/DK0783302T3/da active
- 1995-09-27 BR BR9509108A patent/BR9509108A/pt not_active IP Right Cessation
- 1995-09-27 ES ES95932166T patent/ES2140706T3/es not_active Expired - Lifetime
- 1995-09-27 EE EE9700061A patent/EE03380B1/xx not_active IP Right Cessation
- 1995-09-27 CZ CZ1997936A patent/CZ286356B6/cs not_active IP Right Cessation
- 1995-09-27 RU RU97106511/14A patent/RU2157188C2/ru not_active IP Right Cessation
- 1995-09-27 JP JP8511571A patent/JPH10506887A/ja not_active Ceased
- 1995-09-27 KR KR1019970702014A patent/KR100375469B1/ko not_active IP Right Cessation
- 1995-09-27 AP APAP/P/1997/000951A patent/AP742A/en active
- 1995-09-27 GE GEAP19953636A patent/GEP20002140B/en unknown
- 1995-09-27 US US08/809,764 patent/US5849265A/en not_active Expired - Fee Related
- 1995-09-27 MX MX9702149A patent/MX9702149A/es not_active IP Right Cessation
- 1995-09-27 UA UA97031255A patent/UA47412C2/uk unknown
- 1995-09-27 MD MD97-0134A patent/MD1900C2/ro not_active IP Right Cessation
- 1995-09-27 EP EP95932166A patent/EP0783302B1/en not_active Expired - Lifetime
- 1995-09-27 AU AU35321/95A patent/AU707922B2/en not_active Ceased
- 1995-09-27 AT AT95932166T patent/ATE187063T1/de not_active IP Right Cessation
-
1997
- 1997-03-10 IS IS4438A patent/IS1991B/is unknown
- 1997-03-21 OA OA60982A patent/OA10603A/en unknown
- 1997-03-21 BG BG101347A patent/BG62839B1/bg unknown
- 1997-03-25 NO NO19971422A patent/NO313658B1/no unknown
- 1997-03-26 FI FI971279A patent/FI971279A/fi not_active Application Discontinuation
-
1999
- 1999-12-22 GR GR990403333T patent/GR3032245T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE03380B1 (et) | Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod | |
BR9504509A (pt) | Composto processo para sua preparaçao e formulaçao farmaceûtica | |
ITMI950529A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
EE9900075A (et) | 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks | |
EE9700145A (et) | Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid | |
BR9500784A (pt) | Composto e formulação farmacêutica | |
BR9504060A (pt) | Composto e formulação farmacêutica | |
EE9500064A (et) | Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid | |
EE9800136A (et) | Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine | |
EE04042B1 (et) | Suure bioomastatavusega fenofibraatide ravimkoostis ja meetod selle valmistamiseks | |
IL115483A0 (en) | Urea derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
EE03338B1 (et) | Tromboosivastane ravim, selle valmistamise protsess ja kasutamine | |
NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
EE9800119A (et) | Mikrokapseldatud putukamürgi preparaadid ja protsess nende valmistamiseks | |
EE9800302A (et) | Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat | |
EE03825B1 (et) | 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
EE9800200A (et) | Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon | |
EE04119B1 (et) | Külmkuivatamiseks sobiv ravimkoostis ja selle valmistamise meetod | |
EE200000226A (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
BR9506106A (pt) | Composto processo para sua preparação medicamento e composição farmacêutica | |
EE9500020A (et) | Kinoloon- ja naftüridoonkarboksüülhapped ja nende derivaadid, nende valmistamismeetodid ja nimetatud ühendeid sisaldavad ravimid | |
FI960316A0 (fi) | Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
EE03996B1 (et) | Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine | |
FI956278A0 (fi) | Substituoituja 4-fenyylitiatsolijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
EE04260B1 (et) | Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20080927 |